Univ.-Prof. Dr. Dr. Eva Schulte

Management Functions

Since 2023-W2 Professor & Division Head Psychiatric Genomics, Department of Psychiatry and Psychotherapy, University of Bonn, Bonn, Germany
Since 2020-Group leader, Institute of Psychiatric Phenomics and Genomics, University of Munich, Munich, Germany

Since 2022-Board certification Psychiatry & Psychotherapy
Since 2019-Board certification Neurology
2016 to 2023-Resident, Department of Psychiatry and Psychotherapy, University of Munich, Munich, Germany
2009 to 2014-Resident, Department of Neurology, Klinkum rechts der Isar, Technical University of Munich and Institute of Human Genetics, Helmholtz Munich, Munich, Germany

2022-2023-Visiting Research Fellow, Wellcome Sanger Institute, Hinxton, UK
2022-Habilitation, University of Munich, Munich, Germany
2014-Visiting Postdoctoral Fellow, Stanford University, Palo Alto, CA, USA
2013-PhD, Technical University of Munich, Munich, Germany
2012-2013-Visiting PhD Student, Duke University, Durham, NC, USA
2010-Medical Doctorate, University of Freiburg, Freiburg, Germany
2006-Visiting Undergraduate Student, Brigham & Women's Hospital & Harvard Medical School, Boston, MA, USA

Graduate Student Award, Helmholtz Munich 2014 (for best PhD thesis 2013/2014)
American Society for Human Genetics/Charles J. Epstein Trainee Award for Excellence 2013 (semifinalist, pre-doctoral)

for numerous national and international journals such as JAMA Psychiatry and Molecular Psychiatry

International Society for Psychiatric Genetics (ISPG; Genetic Testing Committee 2017 to 2020)
American Society for Human Genetics (ASHG)
National Pandemic Cohort Network (NAPKON) & Network University Medicine (NUM) (FOSA Human Genetics, co-spokesperson)
German Society for Psychiatry, Psychotherapy and Neurology (DGPPN; section "Genetic, Molecular and Cellular Neuroscience")

by the German Research Foundation (DFG), the State of Bavaria and various foundations as well as intramural funds (1.2 million Euros own share of the total third-party funding volume)

Tkachev A*, Stekolshchikova E*, Vanyushkina A, ..., Schulte EC*, Khaitovich P*. Lipid Alteration Signature in the Blood Plasma of Individuals With Schizophrenia, Depression, and Bipolar Disorder. JAMA Psychiatry 2023, 80(3):250-259.
Kalman JL, Burkhardt G, Adorjan K, ..., Schulte EC. Biobanking in everyday clinical practice in psychiatry-The Munich Mental Health Biobank. Front Psychiatry. 2022, 13:934640. PMID: 35935431 (IF 2021: 5.4).
Niemi MEK, Karjalainen J, Liao RG, ..., Schulte EC, et al. Mapping the human genetic architecture of COVID-19. Nature 2021, 600(7889):472-477.
Mullins N, Forstner AJ, O'Connell KS ..., Schulte EC, et al. Genome-wide association study of over 40,000 bipolar disorder cases provides new insights into the underlying biology. Nat Genet 2021, 53(6):817-829.
Wray NR, Ripke S, Mattheisen M, ..., Schulte EC, et al. Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression. Nat Genet 2018, 50, 668-681.
Schulte EC*, Kousi M*, Tan PL, et al. Targeted resequencing and systematic in vivo functional testing identifies rare variants in MEIS1 as significant contributors to restless legs syndrome. Am J Hum Genet 2014, 95:85-95.
Schulte EC, Knauf F, Kemlink D, et al. Variant screening of the coding regions of MEIS1 in patients with restless legs syndrome. Neurology 2011,76:1106-1108.